Managed Healthcare Executive

Previously Incarcerated Vets Not Shortchanged When It Comes to Hepatitis C Care, Study Finds

February 1st 2023

Results suggest that Veterans Health Administration’s outreach efforts to veterans with hepatitis C who had been previously incarcerated could serve as a model.

Though Funding for Telehealth Is Declining, It Doesn't Mean All Virtual Care Isn't Investable

February 1st 2023

It's been reported more often now that funding for telehealth has decreased and it will only continue to do so into the year. Funding has likely decreased because the video/virtual care medium has become a commodity, according to Summus CEO and Founder, Julian Flannery.

For Ulcerative Colitis, Two First-In-Class Candidates and an Interleukin-23 Competition

February 1st 2023

A Swedish and a French company have treatments with novel mechanisms of action in late-stage development. Meanwhile, AbbVie, Janssen and Eli Lilly are vying to get the first interleukin-23 inhibitor for ulcerative colitis on the market.

After a Slow 2022, Healthcare M&A Poised To Pick Up in 2023, Says Bain

February 1st 2023

Larger payers have plenty of cash on hand to do deals but will look for “adjacencies” rather than merger and acquisition with other payers because of the regulatory environment, say Bain experts.

Amgen Launches Amjevita, First Humira Biosimilar on the U.S. Market

January 31st 2023

Amgen says it will sell the first biosimilar to Humira on the U.S. market at two prices.

Featured Content

Take a look at our February issue!

Check out our latest issue of Managed Healthcare Executive! This month's cover story features high deductible alternatives where new health plans are gaining market share by cutting costs.

Medicaid Net Drug Spend Hits Double-Digits for the First Time, Says Magellan Rx Report

Spending on specialty drugs fueled a 11% increase in Medicaid drug spending from 2020 to 2021, says Magellan's seventh annual Medicaid Pharmacy Trend Report.

Insurers Prepare to Fight RADV Rule

January 31, 2023

The Risk Adjustment Data Validation (RADV) rule was finalized today. The new rule for governing how CMS audits Medicare Advantage plans for overpayment due to inflated risk adjustment could cost insurers billions of dollars.

Virtual Care is Evolving into 2023

January 30, 2023

Virtual care has been a favored service among many healthcare consumers as its users have shared they want more out of it, according to a 2022 Virtual Care Survey Report by Summus.

Building Relationships to Improve Access to Healthcare, Improve Health Equity

January 30, 2023

Connecting the healthcare system and patients in a positive, empathetic, respectful way may help lessen the fatigue many groups have with the healthcare system at-large and individual healthcare providers, while improving health equity.

The Future of Savings in Humira Biosimilars Drug Costs Are Low

January 29, 2023

As a dozen Humira Biosimilars are set to enter the market this year, it seems to be unlikely that they will drive down drug costs in the future.

FDA Updates for the Week of Jan. 23, 2023

January 28, 2023

The FDA approved a new drug for type 2 diabetes and a new BTK inhibitor for rare blood cancer while Keytruda got another indication in lung cancer. But Evusheld lost its EUA for COVID-19. The agency accepted an sNDA for Jardiance for CKD and officials said they plan to hold advisory committee meeting for Biogen’s ALS drug.